Volume 21, Number 7—July 2015
Research
Seroprevalence for Hepatitis E and Other Viral Hepatitides among Diverse Populations, Malawi
Table 1
Study name, period (reference) | Study site/setting | Study type | Study population | HIV status | Aims of study |
---|---|---|---|---|---|
ICAR,1989–1994 (21,22) | Queen Elizabeth Central Hospital, Blantyre/urban | Observational cohort | Pregnant and postpartum women | +/– | Assess adverse pregnancy outcomes and rates of mother-to-child transmission of HIV |
SUCOMA, 1998 (23) | Nchalo District, sugar estate/rural, occupational | Observational survey | Adult men | +/– | Identify epidemiologic and biologic determinants of HIV infection in an occupational male cohort |
NVAZ, 2000–2004 (24) | Queen Elizabeth Central Hospital, Blantyre/urban | Randomized clinical trial | Pregnant women | + | Assess efficacy of short antiretroviral post-exposure prophylaxis to prevent mother to child transmission of HIV |
MWANZA, 2001 (T.E. Taha, unpub. data) | Mwanza District/rural | Observational survey | Adult men and women | +/– | Assess risk factors associated with prevalent HIV infection in a rural area adjacent to the borders with Mozambique |
METRO, 2003–2005 (25) | Queen Elizabeth Central Hospital; health centers in Blantyre/urban | Randomized clinical trial | Adult women (nonpregnant) | +/– | Assess the efficacy of intermittent intravaginal metronidazole gel use in reducing bacterial vaginosis infection |
PEPI, 2004–2008 (26) | Queen Elizabeth Central Hospital; health centers in Blantyre/urban | Randomized clinical trial | Pregnant women | + | Assess efficacy of extended antiretroviral postexposure prophylaxis to prevent mother to child transmission of HIV |
*ICAR, International Collaborations on AIDS Research; SUCOMA, a study of prevalence among male workers for the Sugar Company of Malawi; NVAZ, a study of efficacy of nevirapine/zidovudinel postexposure prophylaxis to prevent mother-to-child transmission of HIV; MWANZA, a study of risk factors associated with prevalent HIV infection in the rural town of Malawi; METRO, a study in which efficacy of intravaginal metronidazole gel in reducing bacterial vaginosis was assessed; PEPI, a study of antiretroviral postexposure prophylaxis to prevent mother to child transmission of HIV.
References
- Labrique AB, Kuniholm MH, Nelson K. The global impact of hepatitis E: new horizons for an emerging virus. In: Scheld WM, Grayson ML, Hughes JM, editors. Emerging Infections 9. 9th edition. Herndon (VA): ASM Press; 2010. p. 53–92.
- Teshale EH, Hu DJ, Holmberg SD. The two faces of hepatitis E virus. Clin Infect Dis. 2010;51:328–34 . DOIPubMedGoogle Scholar
- Nelson KE, Kmush B, Labrique AB. The epidemiology of hepatitis E virus infections in developed countries and among immunocompromised patients. Expert Rev Anti Infect Ther. 2011;09:1133–48. DOIPubMedGoogle Scholar
- Jacobs C, Chiluba C, Phiri C, Lisulo MM, Chomba M, Hill PC, Seroepidemiology of hepatitis E virus infection in an urban population in Zambia: strong association with HIV and environmental enteropathy. J Infect Dis. 2014;209:652–7. DOIPubMedGoogle Scholar
- Gerbi GB, Williams R, Bakamutumaho B, Liu S, Downing R, Drobeniuc J, Hepatitis E as a cause of acute jaundice syndrome in northern Uganda, 2010–2012. Am J Trop Med Hyg. 2015;92:411–4. DOIPubMedGoogle Scholar
- Ahmed JA, Moturi E, Spiegel P, Schilperoord M, Burton W, Kassim NH, Heptitis E outbreak, Dadaab refugee camp, Kenya, 2012. Emerg Infect Dis. 2013;19:1010–2.PubMedGoogle Scholar
- Menendez C, Sanchez-Tapias JM, Kahigwa E, Mshinda H, Costa J, Vidal J, Prevalence and mother-to-child transmission of hepatitis viruses B, C, and E in Southern Tanzania. J Med Virol. 1999;58:215–20. DOIPubMedGoogle Scholar
- Stark K, Poggensee G, Hohne M, Bienzle U, Kiwelu I. Schre ier E. Seroepidemiology of TT virus, GBC-C/HGV, and hepatitis viruses B, C, and E among women in rural area of Tanzania. J Med Virol. 2000;62:524–30. DOIPubMedGoogle Scholar
- Kim J-H, Nelson KE, Panzner U, Kasture Y, Labrique AB, Wierzba TF. A systematic review of the epidemiology of hepatitis E virus in Africa. BMC Infect Dis. 2014;14:308. DOIPubMedGoogle Scholar
- Jacobsen KH, Wiersma ST. Hepatitis A virus seroprevalence by age and world region, 1990 and 2005. Vaccine. 2010;28:6653–7. DOIPubMedGoogle Scholar
- World Health Organization. Hepatitis B 2014 [cited 11/03/2014]. http://www.who.int/mediacentre/factsheets/fs204/en/
- World Health Orgamization. Hepatitis C 2014 [cited 11/03/2014]. http://www.who.int/mediacentre/factsheets/fs164/en/#
- Barth RE, Huijgen Q, Taljaard J, Hoepelman AI. Hepatitis B/C and HIV in sub-Saharan Africa: an association between highly prevalent infectious diseases. A systematic review and meta-analysis. Int J Infect Dis. 2010;14:e1024–31. DOIPubMedGoogle Scholar
- Ocama P, Seremba E. Management of HIV and hepatitis C virus infections in resource-limited settings. Curr Opin HIV AIDS. 2010;6:539–45. DOIPubMedGoogle Scholar
- Chasela CS, Wall P, Drobeniuc J, King CC, Teshale E, Hosseinipour MC, Prevalence of hepatitis C virus infection among human immunodeficiency virus-1–infected pregnant women in Malawi: the BAN study. J Clin Virol. 2012;54:318–20. DOIPubMedGoogle Scholar
- Mullis CE, Laeyendecker O, Reynolds S, Ocama P, Jeffrey Quinn J, Boaz I, High frequency of false-positive hepatitis C virus enzyme-linked immunosorbent assay in Rakai, Uganda. Clin Infect Dis. 2013;57:1747–50. DOIPubMedGoogle Scholar
- Franco E, Bagnato B, Marino MG, Meleleo C, Serino L, Zaratti L. Hepatitis B: epidemiology and prevention in developing countries. World J Hepatol. 2012;4:74–80.
- Nyirenda M, Beadsworth MB, Stephany P, Hart CA, Munthali C, Beeching NJ, Prevalence of infection with hepatitis B and C virus and coinfection with HIV in medical inpatients in Malawi. J Infect. 2008;57:72–7. DOIPubMedGoogle Scholar
- Sutcliffe S, Taha TE, Kumwenda NI. Taylor, Liomba GN. HIV-1 prevalence and herpes simplex virus 2, hepatitis C virus, and hepatitis B virus infections among male workers at a sugar estate in Malawi. J Acquir Immune Defic Syndr. 2002;31:90–7. DOIPubMedGoogle Scholar
- Labrique AB, Zaman K, Hossain Z, Saha P, Yunus M, Hossain A, Epidemiology and risk factors of incident hepatitis E virus infections in rural Bangladesh. Am J Epidemiol. 2010;172:952–61. DOIPubMedGoogle Scholar
- Miotti PG, Dallabetta GA, Chiphangwi JD, Liomba G, Saah AJ. A retrospective study of childhood mortality and spontaneous abortion in HIV-1 infected women in urban Malawi. Int J Epidemiol. 1992;21:792–9. DOIPubMedGoogle Scholar
- Taha TE, Dallabetta GA, Hoover DR, Chiphangwi JD, Mtimavalye LA, Liomba GN, Trends of HIV-1 and sexually transmitted diseases among pregnant and postpartum women in urban Malawi. AIDS. 1998;12:197–203. DOIPubMedGoogle Scholar
- Kumwenda NI, Taha TE, Hoover D, Markakis D, Liomba NG, Chiphangwi JD, Three surveys of HIV-1prevalence and risk factors among men working at a sugar estate in Malawi. Sex Transm Dis. 2002;29:366–71. DOIPubMedGoogle Scholar
- Taha TE, Kumwenda NI, Gibbons A, Broadhead RL, Fiscus S, Lema V, Short postexposure prophylaxis in newborn babies to reduce mother-to-child transmission of HIV-1: NVAZ randomised clinical trial. Lancet. 2003;362:1171–7. DOIPubMedGoogle Scholar
- Taha TE, Kumwenda N, Kafulafula G, Makanani B, Nkhoma C, Chen S, Intermittent intravaginal antibiotic treatment of bacterial vaginosis in HIV-uninfected and infected women: a randomized clinical trial. PLoS Clin Trials. 2007;2:e10. DOIPubMedGoogle Scholar
- Kumwenda NI, Hoover DR, Mofenson LM, Thigpen MC, Kafulafula G, Li Q, Extended antiretroviral prophylaxis to reduce breast-milk HIV-1 transmission. N Engl J Med. 2008;359:119–29. DOIPubMedGoogle Scholar
- Bendall R, Ellis V, Ijaz S, Ali R, Dalton H. A comparison of two commercially available anti-HEV IgG kits and a re-evaluation of anti-HEV IgG seroprevalence data in developed countries. J Med Virol. 2010;82:799–805. DOIPubMedGoogle Scholar
- Naing L, Winn T, Rusli BN. Practical issues in calculating the sample size for prevalence studies. Archives of Orofacial Sciences. 2006;1:9–14.
- Malawi Demographic and Health Survey 2010: Final Report. National Statistics Office of Malawi (Zomba, Malawi) and MEASURE DHS/ICF Macro (Calverton, USA); 2011 [cited 11/03/2014]. http://dhsprogram.com/pubs/pdf/FR247/FR247.pdf
- Kuniholm MH, Labrique AB, Nelson KE. Should HIV-infected patients with unexplained chronic liver enzyme elevations be tested for hepatitis E Virus? Clin Infect Dis. 2010;50:1545–6. DOIPubMedGoogle Scholar
Page created: June 12, 2015
Page updated: June 12, 2015
Page reviewed: June 12, 2015
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.